Table 1. Characteristics of Women With and Without Preeclampsia at Baseline and Final Visits.
| Characteristica | Mean (SD) | |||||
|---|---|---|---|---|---|---|
| Baseline visit | Final visit | |||||
| With preeclampsia (n = 169) | Without preeclampsia (n = 1266) | P value | With preeclampsia (n = 169) | Without preeclampsia (n = 1266) | P value | |
| Age, y | 44.4 (7.7) | 48.9 (7.7) | <.001 | 77.5 (11.0) | 77.5 (10.2) | .95 |
| Weight, kgb | 65.2 (12.4) | 65.1 (11.3) | .94 | 62.3 (14.9) | 61.2 (12.4) | .31 |
| Total cholesterol, mg/dL | 226.2 (48.3) | 234.4 (44.8) | .03 | 256.5 (56.5) | 263.6 (52.7) | .10 |
| Blood glucose, mg/dL | 81.3 (12.9) | 83.0 (21.0) | .30 | 113.9 (55.2) | 104.4 (45.7) | .01 |
| Phospholipids, mg/dL | 200.6 (53.4) | 205.2 (55.9) | .31 | 282.6 (50.4) | 291.8 (48.8) | .02 |
| Blood pressure, mm Hg | ||||||
| Systolic | 138.3 (26.1) | 134.9 (24.2) | .09 | 147.5 (25.9) | 145.3 (25.3) | .28 |
| Diastolic | 86.4 (13.3) | 83.6 (12.4) | .006 | 74.4 (14.0) | 74.9 (13.3) | .64 |
| Receiving treatment for hypertension, No. (%) | 13 (7.7) | 62 (4.9) | .13 | 96 (56.8) | 565 (44.6) | .003 |
| Receiving treatment for hyperlipidemia, No. (%) | 4 (2.4) | 5 (0.4) | .002 | 19 (11.2) | 36 (2.8) | <.001 |
| Current smoking, No. (%) | 81 (47.9) | 465 (36.7) | .005 | 28 (16.6) | 218 (17.2) | .84 |
a
SI conversion factors: To convert total cholesterol to millimoles per liter, multiply by 0.0259; glucose to millimoles per liter, multiply by 0.0555.
b
Weight has been converted to kilograms from pounds, which was the original unit of measurement reported in the Framingham Heart Study. To convert from kilograms to pounds, multiply by 2.205.